Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Prenatal and early life exposure to indoor air-polluting factors and allergic sensitization at 2 years of age.

Gallant MJ, Ellis AK.

Ann Allergy Asthma Immunol. 2019 Nov 22. pii: S1081-1206(19)31449-8. doi: 10.1016/j.anai.2019.11.019. [Epub ahead of print]

PMID:
31765814
2.

Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen season.

Ellis AK, Frankish CW, Armstrong K, Steacy L, Tenn MW, Pawsey S, Hafner RP.

J Allergy Clin Immunol. 2019 Sep 27. pii: S0091-6749(19)31246-1. doi: 10.1016/j.jaci.2019.09.010. [Epub ahead of print]

PMID:
31568796
3.

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?

Ellis AK, Gagnon R, Hammerby E, Lau A.

Allergy Asthma Clin Immunol. 2019 Apr 27;15:27. doi: 10.1186/s13223-019-0344-3. eCollection 2019.

4.

Comparison of allergic rhinitis outcomes of the environmental exposure unit and nasal allergen challenge model.

Tenn MW, Steacy LM, Adams DE, Walker TJ, Ellis AK.

Ann Allergy Asthma Immunol. 2019 Jul;123(1):105-106.e1. doi: 10.1016/j.anai.2019.04.003. Epub 2019 Apr 6. No abstract available.

PMID:
30959101
5.

Clinical standardization of two controlled allergen challenge facilities: The Environmental Exposure Unit and the Biogenics Research Chamber.

Ellis AK, Jacobs RL, Tenn MW, Steacy LM, Adams DE, Walker TJ, Togias A, Ramirez DA, Andrews CP, Visness CM, James RL, Rather CG.

Ann Allergy Asthma Immunol. 2019 Jun;122(6):639-646.e2. doi: 10.1016/j.anai.2019.03.007. Epub 2019 Mar 13.

PMID:
30878629
6.

The microbiome of the nose.

Rawls M, Ellis AK.

Ann Allergy Asthma Immunol. 2019 Jan;122(1):17-24. doi: 10.1016/j.anai.2018.05.009. Review. No abstract available.

PMID:
30579432
7.

Allergen-specific immunotherapy.

Moote W, Kim H, Ellis AK.

Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):53. doi: 10.1186/s13223-018-0282-5. eCollection 2018. Review.

8.

Anaphylaxis.

Fischer D, Vander Leek TK, Ellis AK, Kim H.

Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):54. doi: 10.1186/s13223-018-0283-4. eCollection 2018. Review.

9.

Peripheral group 2 innate lymphoid cells are decreased following nasal allergen challenge in allergic rhinitis.

Tenn MW, Thiele J, Steacy LM, Adams DE, Ellis AK.

Allergy. 2019 Feb;74(2):388-391. doi: 10.1111/all.13614. Epub 2018 Dec 16. No abstract available.

PMID:
30243027
10.

Nasal challenges in allergen immunotherapy trials.

Tenn MW, Rawls M, Ellis AK.

Curr Opin Allergy Clin Immunol. 2018 Dec;18(6):489-494. doi: 10.1097/ACI.0000000000000482. Review.

PMID:
30199379
11.

Aeroallergens in Canada: Distribution, Public Health Impacts, and Opportunities for Prevention.

Sierra-Heredia C, North M, Brook J, Daly C, Ellis AK, Henderson D, Henderson SB, Lavigne É, Takaro TK.

Int J Environ Res Public Health. 2018 Jul 25;15(8). pii: E1577. doi: 10.3390/ijerph15081577. Review.

12.

Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort Study.

Liu EY, Smith LM, Ellis AK, Whitaker H, Law B, Kwong JC, Farrington P, Lévesque LE.

CMAJ. 2018 May 28;190(21):E648-E655. doi: 10.1503/cmaj.170871.

13.

The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.

Neighbour H, Soliman M, Steacy LM, Hickey P, Forbes B, Larché M, Ellis AK.

Clin Transl Allergy. 2018 Apr 12;8:15. doi: 10.1186/s13601-018-0198-7. eCollection 2018.

14.

Severity of allergic rhinitis assessed by using urine metabolomic profiling: Proof of concept.

Adamko DJ, Khamis MM, Steacy LM, Regush S, Bryce R, Ellis AK.

J Allergy Clin Immunol. 2018 Aug;142(2):687-689.e6. doi: 10.1016/j.jaci.2018.02.051. Epub 2018 Apr 17. No abstract available.

PMID:
29678748
15.

Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.

Ellis AK, Tenn MW, Steacy LM, Adams DE, Day AG, Walker TJ, Nolte H.

Ann Allergy Asthma Immunol. 2018 May;120(5):495-503.e2. doi: 10.1016/j.anai.2018.02.003. Epub 2018 Feb 9.

PMID:
29432967
16.

Repeatability of nasal allergen challenge results: Further validation of the allergic rhinitis clinical investigator collaborative protocols.

Soliman M, Steacy LM, Thiele J, Adams DE, Neighbour HL, Ellis AK.

Ann Allergy Asthma Immunol. 2018 Jun;120(6):607-613. doi: 10.1016/j.anai.2018.02.009. Epub 2018 Feb 9.

PMID:
29432965
17.

What can we learn about predictors of atopy from birth cohorts and cord blood biomarkers?

Gallant MJ, Ellis AK.

Ann Allergy Asthma Immunol. 2018 Feb;120(2):138-144. doi: 10.1016/j.anai.2017.12.003. Review. No abstract available.

PMID:
29413337
18.
19.

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens.

Quirt J, Gagnon R, Ellis AK, Kim HL.

Allergy Asthma Clin Immunol. 2018 Jan 9;14:1. doi: 10.1186/s13223-017-0225-6. eCollection 2018. Review. No abstract available.

20.

Acute generalized exanthematous pustulosis with multisystem manifestations: Pinpoint pustules and purulent lakes.

Rosen A, Del Paggio JC, Chan B, Abu-Abed S, Rawls M, Ellis AK.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):92-94. doi: 10.1016/j.anai.2017.09.077. No abstract available.

PMID:
29273137
21.

Asthma biomarkers in the age of biologics.

Kim H, Ellis AK, Fischer D, Noseworthy M, Olivenstein R, Chapman KR, Lee J.

Allergy Asthma Clin Immunol. 2017 Nov 17;13:48. doi: 10.1186/s13223-017-0219-4. eCollection 2017. Review.

22.

Advances in rhinitis: Models and mechanisms.

Ellis AK, Tenn MW.

Ann Allergy Asthma Immunol. 2018 Jul;121(1):61-64. doi: 10.1016/j.anai.2017.10.008. Epub 2017 Nov 20. Review.

PMID:
29157860
23.

Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge.

Kim YW, Singh A, Shannon CP, Thiele J, Steacy LM, Ellis AK, Neighbour H, Gliddon DR, Hickey PLC, Larché M, Tebbutt SJ.

J Immunol. 2017 Nov 15;199(10):3395-3405. doi: 10.4049/jimmunol.1700378. Epub 2017 Oct 18.

24.

Do Corticosteroids Prevent Biphasic Anaphylaxis?

Alqurashi W, Ellis AK.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1194-1205. doi: 10.1016/j.jaip.2017.05.022. Review.

PMID:
28888249
25.

Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit.

North ML, Jones MJ, MacIsaac JL, Morin AM, Steacy LM, Gregor A, Kobor MS, Ellis AK.

Allergy. 2018 Jan;73(1):196-205. doi: 10.1111/all.13263. Epub 2017 Sep 22.

PMID:
28755526
26.

Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.

Ellis AK, Tsitoura DC, Quint D, Powley W, Lee LA.

Clin Exp Allergy. 2017 Sep;47(9):1193-1203. doi: 10.1111/cea.12974. Epub 2017 Aug 11.

PMID:
28681506
27.

Advanced clinical testing of the adaptive immune system.

Erdle S, Ellis AK, Upton JEM.

Ann Allergy Asthma Immunol. 2017 Jun;118(6):655-663. doi: 10.1016/j.anai.2017.04.007. Review. No abstract available.

PMID:
28583259
28.

Let's Talk Period! Preliminary results of an online bleeding awareness knowledge translation project and bleeding assessment tool promoted on social media.

Reynen E, Grabell J, Ellis AK, James P.

Haemophilia. 2017 Jul;23(4):e282-e286. doi: 10.1111/hae.13271. Epub 2017 May 24.

PMID:
28544019
29.

The Kingston Allergy Birth Cohort: Exploring parentally reported respiratory outcomes through the lens of the exposome.

North ML, Brook JR, Lee EY, Omana V, Daniel NM, Steacy LM, Evans GJ, Diamond ML, Ellis AK.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):465-473. doi: 10.1016/j.anai.2017.01.002. Epub 2017 Mar 8.

PMID:
28284980
30.

Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.

Ellis AK, Frankish CW, O'Hehir RE, Armstrong K, Steacy L, Larché M, Hafner RP.

J Allergy Clin Immunol. 2017 Aug;140(2):486-496. doi: 10.1016/j.jaci.2016.11.043. Epub 2017 Feb 21.

PMID:
28236469
31.

Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.

Pfaar O, Calderon MA, Andrews CP, Angjeli E, Bergmann KC, Bønløkke JH, de Blay F, Devillier P, Ellis AK, Gerth van Wijk R, Hohlfeld JM, Horak F, Jacobs RL, Jacobsen L, Jutel M, Kaul S, Larché M, Larenas-Linnemann D, Mösges R, Nolte H, Patel P, Peoples L, Rabin RL, Rather C, Salapatek AM, Sigsgaard T, Thaarup S, Yang J, Zieglmayer P, Zuberbier T, Demoly P.

Allergy. 2017 Jul;72(7):1035-1042. doi: 10.1111/all.13133. Epub 2017 May 4. Review.

PMID:
28122133
32.

The year in review: The best of 2016 in the Annals.

Marshall GD Jr, Bielory L, Walter Canonica G, Desai M, Ellis AK, Hsieh FH, Grayson MH, Greenhawt M, Lieberman JA, Montanaro A, Oppenheimer J.

Ann Allergy Asthma Immunol. 2017 Jan;118(1):4-9. doi: 10.1016/j.anai.2016.11.005. Review. No abstract available.

PMID:
28007087
33.

The clinical relevance of filaggrin mutations: Effect on allergic disease.

Tenn MW, Ellis AK.

Ann Allergy Asthma Immunol. 2016 Nov;117(5):483-489. doi: 10.1016/j.anai.2016.03.027. Epub 2016 Oct 24. Review. No abstract available.

PMID:
27788876
34.

Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU).

Ellis AK, Soliman M, Steacy LM, Adams DE, Hobsbawn B, Walker TJ.

Allergy Asthma Clin Immunol. 2016 Oct 19;12:53. eCollection 2016.

35.

Administering multiple cumulative allergen challenges: An alternative nasal allergen challenge protocol for the Allergic Rhinitis-Clinical Investigator Collaborative.

Soliman M, Steacy L, Thiele J, Adams D, Neighbour H, Ellis AK.

Ann Allergy Asthma Immunol. 2016 Sep;117(3):326-8. doi: 10.1016/j.anai.2016.06.025. No abstract available.

PMID:
27613467
36.

Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit.

Ellis AK, Steacy LM, Joshi A, Bhowmik S, Raut A.

Ann Allergy Asthma Immunol. 2016 Sep;117(3):310-7. doi: 10.1016/j.anai.2016.07.018.

PMID:
27613466
37.

Mobile health applications in clinical practice: pearls, pitfalls, and key considerations.

Cook VE, Ellis AK, Hildebrand KJ.

Ann Allergy Asthma Immunol. 2016 Aug;117(2):143-9. doi: 10.1016/j.anai.2016.01.012. Review. No abstract available.

PMID:
27499542
38.

Novel application of the controlled allergen challenge facility model.

Ellis AK.

Ann Allergy Asthma Immunol. 2016 Jun;116(6):481-2. doi: 10.1016/j.anai.2016.04.028. No abstract available.

PMID:
27264561
39.

Secondary Prevention of Pollen-Induced Allergic Rhinitis-Perhaps Not a Pipe Dream?

Ellis AK, Cox L.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):453-4. doi: 10.1016/j.jaip.2016.02.002. No abstract available.

PMID:
27157936
40.

The year in review: the best of 2015 in the Annals.

Marshall GD Jr, Grayson MH, Ellis AK, Hsieh FH, Oppenheimer J, Desai M, Lieberman JA, Greenhawt M, Montanaro A, Bielory L.

Ann Allergy Asthma Immunol. 2016 Jan;116(1):2-8. doi: 10.1016/j.anai.2015.10.025. No abstract available.

PMID:
26707769
41.

Allergen immunotherapy in pregnancy.

Oykhman P, Kim HL, Ellis AK.

Allergy Asthma Clin Immunol. 2015 Nov 10;11:31. doi: 10.1186/s13223-015-0096-7. eCollection 2015. Review.

42.

Priority role of epinephrine in anaphylaxis further underscored--the impact on biphasic anaphylaxis.

Ellis AK.

Ann Allergy Asthma Immunol. 2015 Sep;115(3):165. doi: 10.1016/j.anai.2015.06.024. No abstract available.

PMID:
26356586
43.

Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research.

North ML, Soliman M, Walker T, Steacy LM, Ellis AK.

Curr Allergy Asthma Rep. 2015 Apr;15(4):11. doi: 10.1007/s11882-015-0514-4. Review.

PMID:
26130471
44.

The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.

Ellis AK, Soliman M, Steacy L, Boulay MÈ, Boulet LP, Keith PK, Vliagoftis H, Waserman S, Neighbour H.

Allergy Asthma Clin Immunol. 2015 Apr 24;11(1):16. doi: 10.1186/s13223-015-0082-0. eCollection 2015.

45.

Year in review: upper respiratory diseases.

Ellis AK, Soliman M.

Ann Allergy Asthma Immunol. 2015 Mar;114(3):168-9. doi: 10.1016/j.anai.2014.12.011. No abstract available.

PMID:
25744899
46.

Expanding role of controlled allergen challenge facilities in allergic rhinitis research.

Ellis AK, North ML.

Ann Allergy Asthma Immunol. 2015 Mar;114(3):159-60. doi: 10.1016/j.anai.2014.12.018. No abstract available.

PMID:
25744895
47.

Case 2: A 13-year-old boy with fever and rash.

Harvey SM, Ellis AK, Johannes CJ.

Paediatr Child Health. 2015 Jan-Feb;20(1):15-6. No abstract available.

48.

Phenotyping allergic rhinitis as early- or dual-phase responses using the environmental exposure unit.

Soliman M, Ellis AK.

Ann Allergy Asthma Immunol. 2015 Apr;114(4):344-5. doi: 10.1016/j.anai.2014.12.020. Epub 2015 Feb 3. No abstract available.

PMID:
25661655
49.

Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU).

Ellis AK, Steacy LM, Hobsbawn B, Conway CE, Walker TJ.

Allergy Asthma Clin Immunol. 2015 Jan 27;11(1):5. doi: 10.1186/s13223-015-0071-3. eCollection 2015.

50.

Air pollution and asthma: how can a public health concern inform the care of individual patients?

North ML, Alexis NE, Ellis AK, Carlsten C.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):343-6. doi: 10.1016/j.anai.2014.07.019. Review. No abstract available.

PMID:
25256028

Supplemental Content

Loading ...
Support Center